Sort
16,300 grants matching “fatty liver disease”
The effects of bile acid receptor activation on non-alcoholic fatty liver disease
$99,268Rachel McMahan · University Of Colorado Denver · K01 · FY2015 · DK
The effects of bile acid receptor activation on non-alcoholic fatty liver disease
$99,268Rachel McMahan · University Of Colorado Denver · K01 · FY2017 · DK
The effects of bile acid receptor activation on non-alcoholic fatty liver disease
$99,266Rachel McMahan · University Of Colorado Denver · K01 · FY2013 · DK
Bariatric Surgery for Morbid Obesity: Clinical and Pathophysiologic Consequences
$99,258Paul David Berk · Columbia University Health Sciences · R01 · FY2010 · DK
CORE D: Magnetic Resonance Imaging Core (MRIC)
$99,115Geoffrey David Clarke · University Of Wyoming · U19 · FY2018 · AG
A novel role for p53 in congenital disorders of glycosylation
$99,036Jaime C Chu · Icahn School Of Medicine At Mount Sinai · K08 · FY2016 · DK
Mechanisms of Metastasis Suppression in the Spleen
$99,014Mark Primeaux · Fred Hutchinson Cancer Center · K00 · FY2025 · CA
Administrative Supplement to Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$98,799Ruth E. Stark · City College Of New York · R16 · FY2023 · GM
Metabolic health phenotype, accelerated aging and obesity-related cancer risk and mortality
$98,771Prasoona Karra · Dartmouth College · K00 · FY2023 · CA
Clinical Research on Non-Alcoholic Steatohepatitis
$98,702Naga P. Chalasani · Indiana University Indianapolis · U01 · FY2008 · DK
Secretion from adipose cells
$98,600Konstantin V. Kandror · Boston University Medical Campus · R01 · FY2010 · DK
Clinical Research Network in Non Alcoholic Steatohepati*
$98,540University Of Washington · U01 · FY2005 · DK
Regulation of lipid metabolism by macroautophagy
$98,474Rajat Singh · Albert Einstein College Of Medicine · K01 · FY2013 · DK
Regulation of lipid metabolism by macroautophagy
$98,474Rajat Singh · Albert Einstein College Of Medicine · K01 · FY2014 · DK
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
$98,375Giuseppe Cullaro · Columbia University Health Sciences · K23 · FY2024 · DK
HCC Risk Stratification in MAFLD Cirrhosis
$98,355Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2024 · CA
Multilevel factors associated with heterogeneity in risk of liver cancer within Hispanics with cirrhosis
$98,355Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2024 · CA
Adipogenesis and Insulin Resistance
$98,288Arthur Sherman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Role of Uhrf1 in Liver Development, Regeneration and Carciogenesis
$98,261Chinweike Ukomadu · Brigham And Women'S Hospital · R01 · FY2012 · DK
The role of hepatocyte tPA in hepatic VLDL production.
$98,149Ze Zheng · Medical College Of Wisconsin · R01 · FY2024 · HL
Evaluation of genetic and metabolic markers in the development of urinary urgency incontinence
$98,134David Sheyn · Case Western Reserve University · R03 · FY2023 · AG
Functional evaluation of a new GWAS locus that links visceral adiposity and type 2 diabetes
$98,061Matthew Steinhauser · Brigham And Women'S Hospital · R01 · FY2019 · DK
Research Training in Bioenergetics, Oxidative Stress & Metabolic Syndromes
$98,013John J Lemasters · Medical University Of South Carolina · T32 · FY2009 · DK
Modulation of Acute Liver Injury
$97,984Mark J. Czaja · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
Factors Controlling Metabolic Flux in the Liver by NMR Isotopomer Analysis
$97,941Shawn C Burgess · Ut Southwestern Medical Center · R01 · FY2010 · DK